NASDAQ : PRVA
Privia Health Group, Inc. — Key statistics
Healthcare · Health Information Services · United States
Last price 21.995 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.81B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.74B |
| Enterprise Value | 2.34B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 127.73M |
| Shares Outstanding | 127.73M |
| Shares Change (YoY) | +2.73% |
| Shares Change (QoQ) | +0.72% |
| Owned by Insiders (%) | 0.49% |
| Owned by Institutions (%) | 81.39% |
| Float | 108.95M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 97.96 |
| Forward PE | 56.42 |
| PS Ratio | 1.16 |
| Forward PS | 1.07 |
| PB Ratio | 3.47 |
| P/TBV Ratio | 7.89 |
| P/FCF Ratio | 20.92 |
| P/OCF Ratio | 20.92 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 83.21 |
| EV / Sales | 0.99 |
| EV / EBITDA | 41.10 |
| EV / EBIT | 52.15 |
| EV / FCF | 17.85 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.62 |
| Quick Ratio | 1.55 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.07 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 4.31% |
| Return on Assets (ROA) | 2.03% |
| Return on Invested Capital (ROIC) | 6.52% |
| Return on Capital Employed (ROCE) | 5.25% |
| Weighted Average Cost of Capital (WACC) | 8.63% |
| Revenue Per Employee | $1.92M |
| Profits Per Employee | $22,940 |
| Employee Count | 1,226 |
| Asset Turnover | 1.71 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 22.27M |
| Effective Tax Rate | 39.69% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.80 |
| 52-Week Price Change | -16.09% |
| 50-Day Moving Average | 20.88 |
| 200-Day Moving Average | 22.67 |
| Relative Strength Index (RSI) | 48.92 |
| Average Volume (20 Days) | 1,152,494 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 5.01M |
| Short Previous Month | 5.81M |
| Short % of Shares Out | 3.92% |
| Short % of Float | 4.60% |
| Short Ratio (days to cover) | 3.57 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.36B |
| Gross Profit | 236.52M |
| Operating Income | 44.88M |
| Pretax Income | 56.11M |
| Net Income | 28.12M |
| EBITDA | 56.94M |
| EBIT | 44.88M |
| Earnings Per Share (EPS) | $0.22 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 412.20M |
| Total Debt | 8.73M |
| Net Cash | 403.47M |
| Net Cash Per Share | $3.16 |
| Equity (Book Value) | 838.07M |
| Book Value Per Share | 6.19 |
| Working Capital | 390.82M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 131.13M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 12.06M |
| Net Borrowing | n/a |
| Free Cash Flow | 131.13M |
| FCF Per Share | $1.03 |
Margins
| Measure | Value |
|---|
| Gross Margin | 10.03% |
| Operating Margin | 1.90% |
| Pretax Margin | 2.38% |
| Profit Margin | 1.19% |
| EBITDA Margin | 2.41% |
| EBIT Margin | 1.90% |
| FCF Margin | 5.56% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.73% |
| Shareholder Yield | -2.73% |
| Earnings Yield | 1.02% |
| FCF Yield | 4.78% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $31.47 |
| Price Target Difference | 46.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (3Y) | 12.57% |
| EPS Growth Forecast (3Y) | 6.47% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.47 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |